Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-12-06

Clinical Trial Update: GAMALINE®+HIPERICIN® for PMS Treatment and Vasomotor Symptoms [Phase 3]

View source ↗

Summary

This notice reports a Phase 3 trial evaluating GAMALINE plus HIPERICIN for premenstrual syndrome and vasomotor symptoms, with current status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GAMALINE
  • HIPERICIN (Hypericin)

Snippet

Sponsor: Phytopharm Consulting Brazil | Conditions: Premenstrual Syndrome, Uterus; Hemorrhage, Preclimacteric or Premenopausal | Phase 3 | Status: UNKNOWN